These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 20667520)

  • 1. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.
    Bruder O; Wagner A; Jensen CJ; Schneider S; Ong P; Kispert EM; Nassenstein K; Schlosser T; Sabin GV; Sechtem U; Mahrholdt H
    J Am Coll Cardiol; 2010 Sep; 56(11):875-87. PubMed ID: 20667520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy.
    Amado LC; Lima JA
    Curr Opin Cardiol; 2010 May; 25(3):276-81. PubMed ID: 20224393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
    Maron MS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
    Miller MA; Gomes JA; Fuster V
    Nat Clin Pract Cardiovasc Med; 2007 Dec; 4(12):667-76. PubMed ID: 18033231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
    Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
    J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy.
    Hoey ET; Teoh JK; Das I; Ganeshan A; Simpson H; Watkin RW
    Clin Radiol; 2014 Mar; 69(3):221-30. PubMed ID: 24412355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
    Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T
    J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
    Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
    Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
    J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between myocardial fibrosis and the occurrence of atrial fibrillation in hypertrophic cardiomyopathy: a cardiac magnetic resonance imaging study.
    Pujadas S; Vidal-Perez R; Hidalgo A; Leta R; Carreras F; Barros A; Bayes-Genis A; Subirana MT; Pons-Llado G
    Eur J Radiol; 2010 Aug; 75(2):e88-91. PubMed ID: 20079992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging.
    Sato Y; Matsumoto N; Kunimasa T; Matsuo S; Yoda S; Tani S; Kunimoto S; Saito S; Hirayama A
    Int J Cardiol; 2008 Dec; 131(1):e41-3. PubMed ID: 17920709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nontransmural scar detected by magnetic resonance imaging and origin of ventricular tachycardia in structural heart disease.
    Yokokawa M; Tada H; Koyama K; Naito S; Oshima S; Taniguchi K
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S52-6. PubMed ID: 19250112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
    Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
    Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Duarte S; Bogaert J
    Rev Port Cardiol; 2010 Jan; 29(1):79-93. PubMed ID: 20391901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of diagnostic and prognostic value of different electrocardiographic criteria to delayed-enhancement magnetic resonance imaging for healed myocardial infarction.
    Krittayaphong R; Maneesai A; Chaithiraphan V; Saiviroonporn P; Chaiphet O; Udompunturak S
    Am J Cardiol; 2009 Feb; 103(4):464-70. PubMed ID: 19195503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances.
    Hansen MW; Merchant N
    AJR Am J Roentgenol; 2007 Dec; 189(6):1344-52. PubMed ID: 18029870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.